13F-HR filed by DAFNA Capital Management LLC
DAFNA Capital Management LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 87 holding rows worth $371,806,000.
- Accession
- 0001389933-22-000010
- Filer
- CIK 1389933
- Filed
- 2022-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 87 entries on the cover page, a total value of $371,806,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $371,806,000 with VALUE read as thousands by filing date, 13F file number 028-12327. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFischel Nathan028-12328
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 566,000 | $44,895,000 | thousands by filing date | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 13,680,554 | $24,625,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 261,235 | $17,213,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 110,100 | $16,644,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 135,712 | $14,014,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 375,223 | $13,546,000 | thousands by filing date | |
| ADICET BIO INC | 007002108 | COM | 935,766 | $13,307,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 539,940 | $12,100,000 | thousands by filing date | |
| ISHARES TR | 464287556 | ISHARES BIOTECH | 102,500 | $11,988,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 479,785 | $9,461,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 183,995 | $8,915,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 355,487 | $8,542,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 80,155 | $8,513,000 | thousands by filing date | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 538,561 | $8,035,000 | thousands by filing date | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 781,112 | $7,686,000 | thousands by filing date | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 566,695 | $7,384,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 401,476 | $7,202,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 180,306 | $7,061,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 28,886 | $6,497,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,703,235 | $5,961,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 72,552 | $5,843,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 276,893 | $5,546,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 195,467 | $5,532,000 | thousands by filing date | |
| ALECTOR INC | 014442107 | COMMON STOCK | 532,438 | $5,037,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 71,600 | $5,001,000 | thousands by filing date | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 475,367 | $4,701,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 178,717 | $4,675,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 307,232 | $4,648,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 65,946 | $4,504,000 | thousands by filing date | |
| CARDIOVASCULAR SYSTEMS INC | 141619106 | COMMON STOCK | 286,988 | $3,978,000 | thousands by filing date | |
| AXOGEN INC | 05463X106 | COM | 332,103 | $3,959,000 | thousands by filing date | |
| 89BIO INC | 282559103 | COM | 654,862 | $3,792,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 255,313 | $3,705,000 | thousands by filing date | |
| F-STAR THERAPEUTICS INC | 30315R107 | COM | 576,881 | $2,954,000 | thousands by filing date | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 122,200 | $2,842,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 206,329 | $2,818,000 | thousands by filing date | |
| ATRICURE INC | 04963C209 | COM | 72,029 | $2,816,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 377,763 | $2,554,000 | thousands by filing date | |
| MEDIWOUND LTD | M68830104 | ORD SHS | 1,428,571 | $1,986,000 | thousands by filing date | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 216,395 | $1,969,000 | thousands by filing date | |
| ACCURAY INC DEL | 004397105 | COM | 941,800 | $1,959,000 | thousands by filing date | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 97,560 | $1,859,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 574,996 | $1,840,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 42,675 | $1,820,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 265,878 | $1,712,000 | thousands by filing date | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 78,500 | $1,592,000 | thousands by filing date | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 552,400 | $1,503,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771VAB4 | NOTE 1.500%10/0 | 1,500,000 | $1,476,000 | thousands by filing date | principal |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 39,000 | $1,467,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 686,282 | $1,414,000 | thousands by filing date | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 413,526 | $1,323,000 | thousands by filing date | |
| SURFACE ONCOLOGY INC | 86877M209 | COM | 1,100,000 | $1,144,000 | thousands by filing date | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 496,150 | $1,062,000 | thousands by filing date | |
| NEURONETICS INC | 64131A105 | COM | 313,717 | $998,000 | thousands by filing date | |
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 74,953 | $980,000 | thousands by filing date | |
| GAMIDA CELL LTD | M47364100 | SHS | 614,896 | $978,000 | thousands by filing date | |
| BIOHAVEN LTD | G1110E107 | COM | 153,564 | $967,000 | thousands by filing date | |
| SCYNEXIS INC | 811292200 | COM NEW | 399,064 | $958,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 1,096,513 | $944,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K309 | COM | 555,555 | $944,000 | thousands by filing date | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 78,074 | $933,000 | thousands by filing date | |
| PARDES BIOSCIENCES INC | 69945Q105 | COM | 479,386 | $887,000 | thousands by filing date | |
| BRAINSWAY LTD | 10501L106 | CMN | 220,000 | $794,000 | thousands by filing date | |
| GENFIT S A | 372279109 | ADS | 187,940 | $686,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 1,767,146 | $683,000 | thousands by filing date | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 52,631 | $612,000 | thousands by filing date | |
| MEDICENNA THERAPEUTICS F | 58490H107 | FOREIGN CANADIAN | 660,000 | $548,000 | thousands by filing date | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 313,600 | $530,000 | thousands by filing date | |
| NEXTCURE INC | 65343E108 | COM | 187,696 | $516,000 | thousands by filing date | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 47,390 | $508,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 649,383 | $483,000 | thousands by filing date | |
| THESEUS PHARMACEUTICALS INC | 88369M101 | COM | 81,899 | $475,000 | thousands by filing date | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 81,200 | $451,000 | thousands by filing date | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 122,517 | $435,000 | thousands by filing date | |
| OTONOMY INC | 68906L105 | COM | 1,470,199 | $434,000 | thousands by filing date | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 188,094 | $429,000 | thousands by filing date | |
| VENUS CONCEPT INC | 92332W105 | COM | 968,187 | $426,000 | thousands by filing date | |
| MASIMO CORP COM | 574795100 | Stock | 3,000 | $423,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 351,064 | $377,000 | thousands by filing date | |
| INOGEN INC | 45780L104 | COM | 15,000 | $364,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 100,000 | $346,000 | thousands by filing date | |
| BIOMEA FUSION INC | 09077A106 | CMN | 34,625 | $339,000 | thousands by filing date | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 125,000 | $250,000 | thousands by filing date | |
| LINEAGE CELL THERAPEUTICS IN | 53566P109 | COMMON STOCK | 140,000 | $158,000 | thousands by filing date | |
| REUNION NEUROSCIENCE INC | 76134G103 | COM | 96,585 | $138,000 | thousands by filing date | |
| COMPUGEN LTD | M25722105 | ORD | 205,202 | $135,000 | thousands by filing date | |
| PHASEBIO PHARMACEUTICALS INC | 717224109 | COM | 321,856 | $57,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001389933-22-000010 | this filing | 2022-11-14 | acceptance time not in the bulk data set |